drugset / Trial / NCT03949478

Treating Postictal Symptoms Using Ibuprofen and Nifedipine

NCT03949478

Phase 2 Unknown 90 enrolled University of Calgary
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the effect of ibuprofen or nifedipine on post-seizure hypoperfusion and neurological deficits in patients with epilepsy. One group will receive ibuprofen, another will receive nifedipine, and anther placebo.

Timeline

Start
2021-02-01
Primary completion
2025-01-01
Completion
2025-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 400 mg Oral
Subject Nifedipine Other / unclassified 20 mg Oral

Indications